HVC
AGN

Healthcare Value Capital’s Allergan plc AGN Stock Holding History

Healthcare Value Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$6.03M – 36
2014
Q3 		$6.03M Buy
+25,000
New +$5.59M 5.82% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Healthcare Value Capital's AGN Position: Q2 2019 in Review

Healthcare Value Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 30,000 shares — an estimated $4.39M sold.

Healthcare Value Capital first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $7.24M in Q3 2014. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Healthcare Value Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Healthcare Value Capital sold 30,000 Allergan plc shares in Q2 2019, an estimated $4.39M.
  • Healthcare Value Capital first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Healthcare Value Capital's Allergan plc position peaked at $7.24M in Q3 2014.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Healthcare Value Capital's 13F filing for Q2 2019, filed 14 Aug 2019.